Relationship between in vitro lipopolysaccharide-induced cytokine response in whole blood, angiographic in-stent restenosis, and toll-like receptor 4 gene polymorphisms

Clinical Chemistry

Volumn 51, Issue 3, 2005, Pages 516-521

  Rittersma, Saskia Z H ^a   Kremer Hovinga, Johanna A ^a   Koch, Karel T ^a   Boekholdt, S Matthijs ^a   Van Aken, Benien E ^a   Scheepmaker, Arko ^a   Bax, Matthijs ^a   Schotborgh, Carl E ^a   Piek, Jan J ^a   Tijssen, Jan G P ^a   Reitsma, Pieter H ^a   De Winter, Robbert J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GENOMIC DNA; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANGIOGRAPHY; ARTICLE; CORONARY STENT; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENDER; GENE AMPLIFICATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OCCLUSION; POLYMERASE CHAIN REACTION; RESTENOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STENT; UNSTABLE ANGINA PECTORIS;

ADULT; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CYTOKINES; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MALE; MEMBRANE GLYCOPROTEINS; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RECEPTORS, CELL SURFACE; STENTS; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 20044388109     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.041277     Document Type: Article

References (27)

1. Welt FG, Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 2002;22:1769-76.
2. Serrano CV Jr, Ramires JA, Venturinelli M, Arie S, D'Amico E, Zweier JL, et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. J Am Coll Cardiol 1997;29:1276-83.
3. Hancock WW, Adams DH, Wyner LR, Sayegh MH, Karnovsky MJ. CD4+ mononuclear cells induce cytokine expression, vascular smooth muscle cell proliferation, and arterial occlusion after endothelial injury. Am J Pathol 1994;145:1008-14.
4. Warle MC, Farhan A, Metselaar HJ, Hop WC, Perrey C, Zondervan PE, et al. Are cytokine gene polymorphisms related to in vitro cytokine production profiles? Liver Transpl 2003;9:170-81.
5. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 2001;276:10229-33.
6. Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000;164:558-61.
7. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002;105:1158-61.
8. Xu XH, Shah PK, Faure E, Equils O, Thomas L, Fishbein MC, et al. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 2001;104:3103-8.
9. Vink A, Schoneveld AH, van der Meer JJ, van Middelaar BJ, Sluijter JP, Smeets MB, et al. In vivo evidence for a role of toll-like receptor 4 in the development of intimai lesions. Circulation 2002;106:1985-90.
10. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000;25:187-91.
11. Boekholdt SM, Agema WR, Peters RJ, Zwinderman AH, van der Wall EE, Reitsma PH, et al. Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation 2003;107:2416-21.
12. Ameziane N, Beillat T, Verpillat P, Chollet-Martin S, Aumont MC, Seknadji P, et al. Association of the toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 2003;23:e61-4.
13. Van der Zwet PM, Reiber JH. A new approach for the quantification of complex lesion morphology: the gradient field transform; basic principles and validation results. J Am Coll Cardiol 1994;24:216-24.
14. Van Aken BE, Reitsma PH, Rosendaal FR. Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol 2002;116:173-7.
15. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning, 2nd ed. New York: Cold Spring Harbor Laboratory, 1989:1659pp.
16. Lorenz E, Frees KL, Schwartz DA. Determination of the TLR4 genotype using allele-specific PCR. Biotechniques 2001;31:22-4.
17. Pietersma A, Kofflard M, de Wit LE, Stijnen T, Koster JF, Serruys PW, et al. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation 1995;91:1320-5.
18. Hojo Y, Ikeda U, Katsuki T, Mizuno O, Fukazawa H, Kurosaki K, et al. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart 2000;84:83-7.
19. Ezhov MV, Sumarokov AB, Raimbekova IR, Masenko VP, Naumov VG. Interleukin 6 but not interleukin 10 is associated with restenosis after coronary stenting. Atherosclerosis 2003;169:193-4.
20. Danenberg HD, Welt FG, Walker M, Seifert P, Toegel GS, Edelman ER. Systemic inflammation induced by lipopolysaccharide increases neointimal formation after balloon and stent injury in rabbits. Circulation 2002;105:2917-22.
21. Feldman U, Aguirre L, Ziol M, Bridou JP, Nevo N, Michel JB, et al. Interleukin-10 inhibits intimai hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. Circulation 2000;101:908-16.
22. Meuwissen M, van der Wal AC, de Winter RJ, Koch KT, Becker AE, Piek JJ. Images in cardiovascular medicine. Stent inflammation: stent footprint in restenotic tissue retrieved by directional atherectomy. Circulation 2002;106:1176-7.
23. Rittersma SZ, De Winter RJ, Koch KT, Schotborgh CE, Bax M, Heyde GS, et al. Preprocedural C-reactive protein is not associated with angiographic restenosis or target lesion revascularization after coronary artery stent placement. Clin Chem 2004;50:1589-96.
24. Van der Linden MW, Huizinga TW, Stoeken DJ, Sturk A, Westendorp RG. Determination of tumour necrosis factor-α and interleukin-10 production in a whole blood stimulation system: assessment of laboratory error and individual variation. J Immunol Methods 1998;218:63-71.
25. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002;347:185-92.
26. Yang IA, Holloway JW, Ye S. TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis. Atherosclerosis 2003;170:187-90.
27. Von Aulock S, Schroder NW, Gueinzius K, Traub S, Hoffmann S, Graf K, et al. Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood. J Infect Dis 2003;188:938-43.